Hurley Capital, LLC Zosano Pharma Corp Transaction History

Hurley Capital, LLC

  • $143 Billion
  • Q2 2025

A detailed history of Hurley Capital, LLC transactions in Zosano Pharma Corp stock. As of the latest transaction made, Hurley Capital, LLC holds 5 shares of ZSANQ stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
N/A
5 New
5 $0

Others Institutions Holding ZSANQ

# of Institutions
1
Shares Held
5
Call Options Held
0
Put Options Held
0
View Full List

About Zosano Pharma Corp

ZSANQ Quotes by TradingView
  • Ticker ZSANQ
  • Exchange OTC
  • Shares Outstandng 4,902,260
  • Description
  • Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The ...
More about ZSANQ
Track This Portfolio

Track Hurley Capital, LLC Portfolio

Follow Hurley Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hurley Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hurley Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email